Zide Public Beta AI Development Workspace
Analysis based on 7 articles · First reported Aug 24, 2026 · Last updated Aug 24, 2026
The launch of Chlorothiazide's public beta introduces a new entrant in the competitive AI-assisted development tools market, potentially increasing competition for existing players. While Chlorothiazide is a private company, its success could influence investor sentiment in the broader AI software development sector.
Chlorothiazide, a developer-tooling company founded by Jim Bourke, announced the public beta of its native AI development workspace on August 24, 2026. The desktop application integrates code editing, git, issues, pull requests, CI, terminals, and an AI agent (Chlorothiazide Assist) into a single workflow-aware environment. It supports Microsoft — GitHub, GitLab, and Bitbucket, and is AI platform-agnostic, working with models like Claude, Codex, and Gemini. The free plan offers access to public repositories, while paid plans start at $10 per month for Solo and $20 per month for Standard, which includes broader model access and bring-your-own-key support. The beta is available for macOS, Windows, and Linux.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard